QCG
NTUS

Quadrant Capital Group’s Natus Medical Inc NTUS Stock Holding History

Quadrant Capital Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-260
Closed -$9K – 2898
2022
Q2 		$9K Buy
+260
New +$8.22K ﹤0.01% 1752
2020
Q2 		– Sell
-23
Closed -$1K – 2471
2020
Q1 		$1K Buy
+23
New +$668 ﹤0.01% 2076
2019
Q1 		– Sell
-247
Closed -$8K – 2362
2018
Q4 		$8K Sell
247
-25
-9% -$813 ﹤0.01% 1486
2018
Q3 		$8K Hold
272
– – ﹤0.01% 1404
2018
Q2 		$8K Hold
272
– – ﹤0.01% 1400
2018
Q1 		$8K Buy
272
+247
+988% +$7.82K ﹤0.01% 1381
2017
Q4 		$0 Hold
25
– – ﹤0.01% 2185
2017
Q3 		$0 Hold
25
– – ﹤0.01% 2192
2017
Q2 		$0 Hold
25
– – ﹤0.01% 2126
2017
Q1 		$0 Hold
25
– – ﹤0.01% 2159
2016
Q4 		$0 Hold
25
– – ﹤0.01% 2101
2016
Q3 		$0 Hold
25
– – ﹤0.01% 2098
2016
Q2 		$0 Sell
25
-4
-14% -$134 ﹤0.01% 2112
2016
Q1 		$1K Buy
+29
New +$1.08K ﹤0.01% 1658

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Quadrant Capital Group's NTUS Position: Q3 2022 in Review

Quadrant Capital Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 260 shares — an estimated $9K sold.

Quadrant Capital Group first reported a position in NTUS in Q1 2016 and held it in 14 quarters. The position peaked at $9K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Quadrant Capital Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 260 Natus Medical Inc shares in Q3 2022, an estimated $9K.
  • Quadrant Capital Group first reported a position in Natus Medical Inc in Q1 2016 and held it in 14 quarters.
  • Quadrant Capital Group's Natus Medical Inc position peaked at $9K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Quadrant Capital Group's 13F filing for Q3 2022, filed 10 Nov 2022.